// // Updates Archive | Page 94 of 212 | Knobbe Martens Skip to content

Partner Kerry Taylor was quoted in, “Lessons From This Year’s High Court Patent Rulings,” an article published by Law360. Excerpt: “It was another busy term for patent law at the U.S. Supreme Court, as the…

Congratulations to Partners Jared Bunker and Jonathan Bachand for being named leading litigation attorneys in Benchmark Litigation’s 2018 “Under 40 Hot List”. Benchmark Litigation exclusively recognizes notable up-and-coming litigation attorneys…

Attorneys Mark Kachner and Karen Weil co-authored “What’s Next For Foreign Patent Damages” which was published on July 2, 2018 in Law360.  Excerpt: The U.S. Supreme Court — in WesternGeco LLC v. Ion Geophysical Corp….

Attorneys Jonathan Hyman, Charlene Azema, and Loni Morrow co-authored “If The IP Fits, Wear It: IP Protection for Footwear – A U.S. Perspective” which was published in the May-June 2018 issue…

Associate Forrest McClellen co-authored, “The Supreme Court, the Federal Circuit, and the Patent Office Walk Out of an Appellate Review Bar: Changing Standards For Appellate Review of IPR Institution Decisions” which was…

Partner Brent Babcock was quoted in, “Patent Awards Give Berkeley a Needed Gene-Edit Boost,” an article published by Bloomberg Law. Excerpt: “The University of California, Berkeley, is on the board in the ongoing…

Partner Brent Babcock was quoted in, “Pharma, Biotech Patent Holders Lament Appeal Board Survival,” an article published by Bloomberg Law. Excerpt: “Pharmaceutical and life sciences patent holders may be unhappy the…

The Supreme Court issued an important pro-patent-owner decision affecting multinational corporations.  In WesternGeco LLC v. ION Geophysical Corp., in a 7-2 decision, the Supreme Court held that a patentee may recover foreign lost profits from an infringer who violates 35 U.S.C. § 271(f)(2) by exporting from the United States a component especially adapted for use in a patented invention.  

Priority Claims Cannot Be Incorporated by Reference In Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited, Appeal Nos. 2016-2707 and 2016-2708, the Federal Circuit held that when a patent for…

Partner Ben Katzenellenbogen was quoted in, “Skilled in the Art: Hatch Wants to Limit Pharma IPRs, but Not Yet,” an article published by Law.com. Excerpt: “The Hatch-Waxman Integrity Act would force generic…

Older posts
- Newer posts